Systematische Übersichtsarbeiten

VERÖFFENTLICHUNGEN (peer-reviewed)

  1. Pioglitazone for type 2 diabetes mellitus. Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd.
  2. Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints. Clar C, Waugh N, Cummins E, Thomas S, McIntyre L. NICE technology assessment report, Health Technology Assessment 2005; Volume 9, No. 47.
  3. Iodine supplementation for preventing iodine deficiency disorders in children (Cochrane Review). Angermayr L, Clar C. In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.
  4. Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitus (Cochrane Review). Clar C, Waugh N, Thomas S. In: The Cochrane Library, Issue 4, 2003. Chichester, UK: John Wiley & Sons, Ltd.
  5. Aspirin in diabetic retinopathy – A systematic review. K Bergerhoff, C Clar, B Richter. Endocrinology and Metabolism Clinics of North America 2002; 31: 779-93.
  6. Glucocorticoid withdrawal schemes in chronic medical disorders – A systematic review. B Richter, G Neises, C Clar. Endocrinology and Metabolism Clinics of North America 2002; 31: 751-78.
  7. Pharmacotherapy for thyroid nodules – A systematic review and meta-analysis. B Richter, G Neises, C Clar. Endocrinology and Metabolism Clinics of North America 2002; 31: 699-722.
  8. Iodised salt for preventing iodine deficiency disorders – A systematic review. C Clar, Wu T, Liu GJ, Li P. Endocrinology and Metabolism Clinics of North America 2000; 31: 681-98.
  9. Systematic reviews in endocrinology – The Cochrane Metabolic and Endocrine Disorders Group. B Richter, C Clar. Endocrinology and Metabolism Clinics of North America 2002; 31: 613-7.
  10. Iodised salt for preventing iodine deficiency disorders (Cochrane Review). Wu T, Liu GJ, Li P, C Clar. In: The Cochrane Library, Issue 3, 2002. Oxford, Update Software.
  11. Fish oil in patients with diabetes mellitus. A Farmer, V Montori, S Dinneen, C Clar. In: The Cochrane Library, Issue 3, 2001. Oxford, Update Software.
  12. Effects of 8 hours of isocapnic hypoxia with and without muscarinic blockade on ventilation and heart rate in humans. C Clar, KL Dorrington, M Fatemian, PA Robbins. Experimental Physiology 2001; 86: 529-38.
  13. The Cochrane Collaboration and its possible impact on diabetes care. B Richter, C Clar, M Berger. Diabetes Care 2000; 23: 1217-8.
  14. Cardiovascular effects of 8 h of isocapnic hypoxia with and without b-blockade in humans. C Clar, KL Dorrington, M Fatemian, PA Robbins. Experimental Physiology 2000; 85: 557-65.
  15. Ventilatory effects of 8 hours of isocapnic hypoxia with and without b-blockade in humans. C Clar, KL Dorrington, PA Robbins. Journal of Applied Physiology 1999; 86: 1897-904.
  16. The human ventilatory response to 8h of euoxic hypercapnia (1998). JG Tansley, MEF Pedersen, C Clar and PA Robbins. Journal of Applied Physiology 1998; 84: 431-4.
  17. Time-course of the human pulmonary vascular response to eucapnic hypoxia. KL Dorrington, C Clar, JD Young, JG Tansley, PA Robbins. American Journal of Physiology 1997; 273: H1126-34.
  18. The human ventilatory response to acute hyperoxia during and after 8 h of both isocapnic and poikilocapnic hypoxia. JG Tansley, C Clar, MEF Pedersen and PA Robbins. Journal of Applied Physiology 1997; 82: 513-9.
  19. Effects of 8 h of isocapnic and poikilocapnic hypoxia on middle cerebral artery velocity and heart rate in humans. C Clar, MEF Pedersen, MJ Poulin, JG Tansley and PA Robbins. Experimental Physiology 1997; 82: 791-802.